According to GlobalData’s medical device pipeline database, 63 Dry Powder Inhaler Devices devices are in various stages of development globally. GlobalData’s report Dry Powder Inhaler Devices provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Of these devices, 43 are in active development, while the remaining 21 are in an inactive stage of development. There are 15 products in the early stages of development, and the remaining 28 are in the late stages of development.
Dry powder inhaler devices deliver medication to the lungs in the form of a dry powder.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Dry Powder Inhaler Devices pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Dry Powder Inhaler Devices devices. Overall, most of these Dry Powder Inhaler Devices pipeline devices are being developed by private entities.
Key players involved in the active development of Dry Powder Inhaler Devices include Iconovo, PureIMS, Lupin Pharmaceuticals, MannKind, Teva Pharmaceutical Industries, Vectura Group, Ology Bioservices, Phargentis, Virginia Commonwealth University and Transpire Bio.
For a complete picture of the developmental pipeline for Dry Powder Inhaler Devices devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.